|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, MA, USA; Cardiovascular Research Center in the Cardiology Division of the Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
2 Cardiovascular Research Center in the Cardiology Division of the Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
3 Ultrasound Laboratory in the Cardiology Division of the Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
4 Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, MA, USA
5 Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
6 Ultrasound Laboratory in the Cardiology Division of the Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Cardiovascular Research Center in the Cardiology Division of the Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: fichinose{at}partners.org.
To investigate the role of endothelial nitric oxide synthase (NOS3) in left ventricular (LV) remodeling induced by chronic pressure-overload, the impact of transverse aortic constriction (TAC) on LV structure and function was compared in wild-type (WT) and NOS3-deficient (NOS3-/-) mice. Before TAC, LV wall thickness, mass, and fractional shortening were similar in the two mouse strains. Twenty-eight days after TAC, both WT
and NOS3-/- mice had increased LV wall thickness and mass, as well as decreased fractional shortening. Although the pressure gradient across the TAC was similar in both strains of mice 28 days after TAC, LV mass and posterior wall thickness were greater in
NOS3-/- than in WT mice, while fractional shortening and the maximum rate of developed LV pressure (dP/dtmax) were less. Diastolic function, as measured by the time constant of isovolumic relaxation (
) and the maximum rate of LV pressure decay
(dP/dtmin), was impaired to a greater extent in NOS3-/- than in WT mice. The degree of myocyte hypertrophy and LV fibrosis was greater in NOS3-/- than in WT mice at 28 days after TAC. Mortality was greater in NOS3-/- than in WT mice 28 days after TAC. Longterm administration of hydralazine normalized the blood pressure and prevented the LV dilation in NOS3-/- mice, but did not prevent the LV hypertrophy, dysfunction, and fibrosis associated with NOS3-deficiency after TAC. These results suggest that the absence of NOS3 augments LV dysfunction and remodeling in a murine model of
chronic pressure-overload.
This article has been cited by other articles:
![]() |
G. Derumeaux, F. Ichinose, M. J. Raher, J. G. Morgan, T. Coman, C. Lee, J. M. Cuesta, H. Thibault, K. D. Bloch, M. H. Picard, et al. Myocardial Alterations in Senescent Mice and Effect of Exercise Training: A Strain Rate Imaging Study Circ Cardiovasc Imaging, November 1, 2008; 1(3): 227 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Buys, P. Sips, P. Vermeersch, M. J. Raher, E. Rogge, F. Ichinose, M. Dewerchin, K. D. Bloch, S. Janssens, and P. Brouckaert Gender-specific hypertension and responsiveness to nitric oxide in sGC{alpha}1 knockout mice Cardiovasc Res, July 1, 2008; 79(1): 179 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Skurk, F. Wittchen, L. Suckau, H. Witt, M. Noutsias, H. Fechner, H.-P. Schultheiss, and W. Poller Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy Eur. Heart J., May 1, 2008; 29(9): 1168 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sharma, S. Dhingra, N. Khaper, and P. K. Singal Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1384 - H1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Buys, M. J. Raher, S. L. Blake, T. G. Neilan, A. R. Graveline, J. J. Passeri, M. Llano, T. M. Perez-Sanz, F. Ichinose, S. Janssens, et al. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H620 - H627. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhang, X. Xu, X. Hu, E. D. van Deel, G. Zhu, and Y. Chen Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload-Induced Ventricular Hypertrophy and Congestive Heart Failure Circ. Res., April 13, 2007; 100(7): 1089 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wenzel, C. Rohde, S. Wingerning, J. Roth, G. Kojda, and K.-D. Schluter Lack of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Formation Favors Hypertrophy in Adult Ventricular Cardiomyocytes Hypertension, January 1, 2007; 49(1): 193 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jung, H. Kubo, R. Wilson, S. R. Houser, and K. B. Margulies Modulation of contractility by myocyte-derived arginase in normal and hypertrophied feline myocardium Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1756 - H1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. M. Greer, D. P. Ware, and D. J. Lefer Myocardial infarction and heart failure in the db/db diabetic mouse Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H146 - H153. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ruetten, S. Dimmeler, D. Gehring, C. Ihling, and A. M. Zeiher Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload Cardiovasc Res, June 1, 2005; 66(3): 444 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Landmesser, F. Bahlmann, M. Mueller, S. Spiekermann, N. Kirchhoff, S. Schulz, C. Manes, D. Fischer, K. de Groot, D. Fliser, et al. Simvastatin Versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans Circulation, May 10, 2005; 111(18): 2356 - 2363. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |